Larry J. Merlo, President and CEO at CVS CAREMARK CORP (CVS), sold 228,875 shares at $70.74 ($16.2M) on 2014-01-02, disclosed to the SEC on 2014-01-03.
Scheduled sale ($16.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.74 | 68,044 | $4.8M | 29.7% |
| 2 | $70.75 | 46,393 | $3.3M | 20.3% |
| 3 | $70.75 | 68,045 | $4.8M | 29.7% |
| 4 | $70.80 | 46,393 | $3.3M | 20.3% |
| Total | $70.76 avg | 228,875 | $16.2M | 100% |
| Filing → |
| CVS | SELL | 2020-01-17 | $39.9M | — | Filing → |
| CVS | SELL | 2019-02-04 | $21.5M | — | Filing → |
| CVS | SELL | 2019-01-10 | $11.5M | — | Filing → |